This diary belongs to Tom, Iâm married with two small c...
Read More The Diary of a Pharmaceutical QA QC Analyst Aged 35 Part 2
Challenging Pharmaceutical Impurity Analysis Part 2: Can IC and ...
In my last blog post, â Challenging pharmaceutical impu...
Read More Challenging Pharmaceutical Impurity Analysis Part 2: Can IC and IC-MS Fill the Gaps?
The Diary of a Pharmaceutical QA/QC Analyst, Aged 35 ¾
This diary belongs to Tom, Iâm married with two small c...
Read More The Diary of a Pharmaceutical QA/QC Analyst, Aged 35 ¾
Predicting the Future for Pharmaceutical Impurities Roundtable
We recently conducted a pharmaceutical impurity webinar seri...
Read More Predicting the Future for Pharmaceutical Impurities Roundtable
That pesky NDMA is causing problems again now with Ranitidine
It was not so long ago when Valsartan manufacturers started ...
Read More That pesky NDMA is causing problems again now with Ranitidine
Let’s Talk About the Elephant in the Lab Spreadsheets and ...
Foreword by Brian Alliston: Surrounded by likeminded industr...
Read More Let’s Talk About the Elephant in the Lab Spreadsheets and Data
Rapid Automated Peptide Mapping
The growth of bioâtherapeutics has occurred mainly due ...
Read More Rapid Automated Peptide Mapping
Pharmaceutical Impurities: Top Four Questions
Over the past year, myself and Dr. Christian Zeine of LGC , ...
Read More Pharmaceutical Impurities: Top Four Questions
Tips for Validating Your Chromatography Data System
Reading through some recent U.S. FDA Warning Letters to phar...
Read More Tips for Validating Your Chromatography Data System
Demonstrating Compliance Through Audit Trail Review
"You have all these audit trails, which provide great i...
Read More Demonstrating Compliance Through Audit Trail Review